Can we detect women with low bone mass using clinical risk factors?

https://doi.org/10.1016/S0002-9343(05)80047-6Get rights and content

Abstract

The magnitude of osteoporosis, the establishedrelationship between low bone mass and the risk of fracture, and the availability of preventive treatment suggest that the early detection of women with low bone mass is justified. The feasibility of population screening using bone mass measurements remains controversial. Another approach is the use of clinical risk factors to detect women at high risk. However, several studies have demonstrated that the assessment of risk factor status does not appear to be an efficient tool for the identification of perimenopausal women with low bone mass. The poor performance of the prediction models might be explained in part by unmeasured factors, especially genetic factors, which are an important determinant of bone mass. On the other hand, the clinical usefulness of clinical risk factors needs to be more precisely evaluated, especially in the detection of women at high risk for hip fracture.

References (28)

  • MeltonL.J. et al.

    Influence of breastfeeding and other reproductive factors on bone mass later in life

    Osteoporosis Int

    (1993)
  • NguyenT.V. et al.

    Lifestyle factors and bone density in the elderly: implications for osteoporosis prevention

    J Bone Min Res

    (1994)
  • GärdsellP. et al.

    Osteoporosis and heredity

    Clin Orthop

    (1989)
  • CooperC. et al.

    Screening for vertebral osteoporosis using individual risk factors

    Osteoporosis Int

    (1991)
  • Cited by (55)

    • Dual X-ray Absorptiometry in Today's Clinical Practice

      2010, Radiologic Clinics of North America
      Citation Excerpt :

      Several risk assessment tools have been developed to identify those at higher risk for osteoporosis. These include the Simple Calculated Osteoporosis Risk Estimation (SCORE); the Osteoporosis Risk Assessment Instrument (ORAI); the Osteoporosis Index of Risk (OSIRIS); Age, Body, Size, No Estrogen (ABONE); and the Osteoporosis Self-Assessment Tool (OST).60,61 In general, these tools rely on common clinical risk factors for low BMD including height loss, low body weight, advanced age, late age of menarche, menopausal, smoking, alcohol use, and low dietary calcium.60

    View all citing articles on Scopus
    View full text